NIH Awards New Grants to Build Capacity in Informatics in Global Health
News Oct 16, 2009
Fogarty's Informatics Training for Global Health program is intended to increase informatics expertise in low- and middle-income countries by training scientists to design information systems and apply computer-supported management and analysis to biomedical research. Medicine and biomedical research are knowledge-based fields that depend upon the sharing of information. Informatics, the science of handling large volumes of information, can help link physicians and researchers around the world so that they can share knowledge ranging from the best care of patients to issues in collaborative research.
"The application of informatics allows our clinicians in low-resource settings to leverage new technologies in order to speed discoveries," said Fogarty Director Roger I. Glass, M.D, Ph.D. "These new awards will enable researchers to better analyze data, compare results among populations and quickly share findings with colleagues around the world."
The grants are being awarded to both new and ongoing informatics programs at various international sites.
Researchers Fine-Tune Computer-Assisted Drug Repositioning Process to Treat Rare DiseasesNews
Researchers at the LSU Computational Systems Biology group have developed a sophisticated and systematic way to identify existing drugs that can be repositioned to treat a rare disease or condition.READ MORE
Living on the Edge: Supercomputing Powers Protein AnalysisNews
Computing techniques, also used on social networks, can help scientists views the connections between our proteins. The technique visualizes proteins as 'nodes' and the connections between the proteins as 'edges'.READ MORE
'Instagram' of Immune System: Researchers Hope to Advance the Field of ImmunotherapyNews
Using artificial intelligence and bioinformatics, researchers can create a two-dimensional mapping that can read test results, creating an Instagram of millions of blood cells. "It's an easy way to look at a complex response such as one you would find during immunotherapy."READ MORE